The efficiency of primary hepatic carcinoma using transcatheter arterial chemoembolization and the bone marrow mesenchymal stem cells

Jian-sheng ZHI,Xiu-juan ZHAO,Zhen-hua QIAO
DOI: https://doi.org/10.3760/cma.j.issn.1006-9801.2007.04.012
2007-01-01
Abstract:Objective To evaluate the efficiency of primary hepatic carcinoma(PHC)using tran- scatheter arterial chemoembolization(TALE)combining with MSC.Methods Treatment group(30 patients with unresectable PHC)adopt MSC after TALE,while control group(10 patients with unresectable PHC)only adopt TALE,then observing the curative effect and survival rate.Results One year after treating,the local effect was 90 %,60 %,1~2 year survival rate was 90 %,30 % respectively,median life span was 15 months. Conclusion To treat PHC with TALE combining with MSC is an effective and non-invasive method.
What problem does this paper attempt to address?